D-059-2013 Class II Terminated
FDA drug recall D-059-2013 was initiated by Dr. Reddy's Laboratories, Inc. on Sep 27, 2012 and is designated Class II. Reason for recall: Failed USP Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg. The recall status is terminated (terminated Jul 10, 2013). Affected quantity: 1512 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 28, 2012
- Initiation Date
- Sep 27, 2012
- Termination Date
- Jul 10, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1512 bottles
Product description
Dr. Reddy's Quetiapine Fumarate Tablets, 25mg, Rx Only, 500 tablets. Mfd By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325, India NDC 55111-249-05
Reason for recall
Failed USP Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.
Distribution pattern
Nationwide. No foreign consignees.
Code information
Lot C203090 Exp.03/14
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-059-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026